Literature DB >> 16146695

Cloning, expression, purification, and characterization of Streptococcus pneumoniae IgA1 protease.

V Romanello1, M Marcacci, F Dal Molin, M Moschioni, S Censini, A Covacci, A G Baritussio, C Montecucco, F Tonello.   

Abstract

The IgA1 protease of Streptococcus pneumoniae is a Zn-metalloproteinase of 1964 amino acids that specifically cleaves the hinge region of IgA1, the predominant class of immunoglobulin present on mucosal membranes. This protease is associated to the bacterial cell surface via an N-terminal membrane anchor. Following proteolysis it is released in several forms of different molecular weight. Here, we describe the cloning, expression, and characterization of the enzymatic activity and immunogenicity of three fragments of IgA1 protease, including a large one lacking only the 103 N-terminal amino acids that constitute a typical prokaryotic signal sequence. Further, a proteolytically inactive mutant was generated by replacement of the glutamate residue with an alanine residue in the active site motif HExxH (1605-1609). This is the first report of recombinant active forms of S. pneumoniae IgA1 protease, which open the possibility of identifying specific inhibitors that could interfere with the mucosal colonization by pneumococcus. Moreover the inactive mutant could be considered as a candidate vaccine component.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16146695     DOI: 10.1016/j.pep.2005.07.015

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  9 in total

1.  Immunization with a ZmpB-based protein vaccine could protect against pneumococcal diseases in mice.

Authors:  Yi Gong; Wenchun Xu; Yali Cui; Xuemei Zhang; Run Yao; Dairong Li; Hong Wang; Yujuan He; Ju Cao; Yibing Yin
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

2.  Development of a high-throughput screen and its use in the discovery of Streptococcus pneumoniae immunoglobulin A1 protease inhibitors.

Authors:  Amanda L Garner; Jessica L Fullagar; Joshua A Day; Seth M Cohen; Kim D Janda
Journal:  J Am Chem Soc       Date:  2013-06-28       Impact factor: 15.419

3.  The expression of soluble and active recombinant Haemophilus influenzae IgA1 protease in E. coli.

Authors:  Shinong Long; Elaine Phan; Michel C Vellard
Journal:  J Biomed Biotechnol       Date:  2010-11-30

4.  Streptococcus pneumoniae IgA1 protease: A metalloprotease that can catalyze in a split manner in vitro.

Authors:  Ying-Chih Chi; Jeremy T Rahkola; Agnieszka A Kendrick; Michael J Holliday; Natasia Paukovich; Thomas S Roberts; Edward N Janoff; Elan Z Eisenmesser
Journal:  Protein Sci       Date:  2017-02-23       Impact factor: 6.725

5.  New adhesin functions of surface-exposed pneumococcal proteins.

Authors:  Cécile Frolet; Meryam Beniazza; Laure Roux; Benoit Gallet; Marjolaine Noirclerc-Savoye; Thierry Vernet; Anne Marie Di Guilmi
Journal:  BMC Microbiol       Date:  2010-07-12       Impact factor: 3.605

6.  Pneumococcal IgA1 protease subverts specific protection by human IgA1.

Authors:  E N Janoff; J B Rubins; C Fasching; D Charboneau; J T Rahkola; A G Plaut; J N Weiser
Journal:  Mucosal Immunol       Date:  2013-07-03       Impact factor: 7.313

7.  Occurrence and evolution of the paralogous zinc metalloproteases IgA1 protease, ZmpB, ZmpC, and ZmpD in Streptococcus pneumoniae and related commensal species.

Authors:  Malene Bek-Thomsen; Knud Poulsen; Mogens Kilian
Journal:  MBio       Date:  2012-10-02       Impact factor: 7.867

8.  Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae.

Authors:  Francesca De Paolis; Elisa Beghetto; Andrea Spadoni; Francesca Montagnani; Franco Felici; Marco R Oggioni; Nicola Gargano
Journal:  BMC Microbiol       Date:  2007-12-18       Impact factor: 3.605

9.  Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies.

Authors:  Carmen Giefing; Andreas L Meinke; Markus Hanner; Tamás Henics; Minh Duc Bui; Dieter Gelbmann; Urban Lundberg; Beatrice M Senn; Michael Schunn; Andre Habel; Birgitta Henriques-Normark; Ake Ortqvist; Mats Kalin; Alexander von Gabain; Eszter Nagy
Journal:  J Exp Med       Date:  2007-12-31       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.